Which of the following is characteristically associated with proliferative diabetic retinopathy: September 2011
## **Core Concept**
Proliferative diabetic retinopathy (PDR) is a complication of diabetes mellitus characterized by the growth of new, fragile blood vessels in the retina. This condition occurs in response to retinal ischemia, leading to the release of vascular endothelial growth factors (VEGF). The hallmark of PDR is neovascularization.
## **Why the Correct Answer is Right**
The correct answer, **neovascularization**, is a pathognomonic feature of proliferative diabetic retinopathy. Neovascularization refers to the formation of new blood vessels, which in the context of PDR, grow from the existing retinal vessels onto the surface of the retina or into the vitreous. This process is a response to retinal hypoxia and ischemia. The newly formed vessels are fragile and prone to bleeding, leading to complications such as vitreous hemorrhage.
## **Why Each Wrong Option is Incorrect**
- **Option A:** While microaneurysms are a feature of diabetic retinopathy, they are more characteristic of the early, non-proliferative stage. Microaneurysms are small outpouchings of retinal capillaries and are not specific to proliferative diabetic retinopathy.
- **Option B:** Cotton wool spots are indicative of retinal ischemia but are not exclusive or diagnostic of proliferative diabetic retinopathy. They can be seen in various retinal vascular diseases.
- **Option C:** Hard exudates are lipid deposits that can occur in diabetic retinopathy, particularly in the background or non-proliferative form. They are not characteristic of the proliferative stage.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the presence of **neovascularization** on fundus examination or fluorescein angiography is diagnostic of proliferative diabetic retinopathy. Early detection and treatment, often with laser photocoagulation or intravitreal anti-VEGF injections, can prevent complications such as vision loss.
## **Correct Answer:** . Neovascularization